Skip to content

Efficacy and safety of Lycium Chinese extract complex on women with osteopenia; A 40week, Randomized, Double-blind, Placebo-Controlled Clinical Trial

Efficacy and safety of Lycium Chinese extract complex on women with osteopenia; A 40week, Randomized, Double-blind, Placebo-Controlled Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0002576
Enrollment
100
Registered
2017-12-01
Start date
2017-01-23
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Subjects will be randomized to receive LAEC or placebo. Subjects will orally self-adminster LAEC or placebo 4 tablets per day for 40weeks.

Sponsors

Dongwoodang
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) female subjects at least more than 45years of age inclusive with menopause a. have no orrhea for 12months b. have last orrhea since 6months ago and FSH > 40mlU/mL c. have both ovariectomy since 6weeks d. have hysterectomy and FSH > 40mlU/mL 2) have Osteopenia by DXA(Dual energy X-ray absorptiometry) 3) BMI of 18.5-35.0kg/m2 4) Subjects who agree the particpation in the trial and submit informed and consent before the beginning of the trial.

Exclusion criteria

Exclusion criteria: 1)The Patients with severe vitamin D which have more than 200IU per day or Calcium before 2weeks from visit2 2)The Patients with severe Bisphosphonate 3)AST(aspartate transaminase), ALT(alanine transaminase) = 2 times the upper limit of normal. 4)eGFR(Estimated glomerular filtration rate) value =60 mL/min/1.73 m2 5)The Patients who had atraumatic fracture or have lumbarcompression fracture 6)Subjects which in the opinion investigator could affect preclude evluation of response

Design outcomes

Primary

MeasureTime frame
DXA(lumbar, femur neck, total hip)

Secondary

MeasureTime frame
bone metabolism index(BALP, Osteocalcin, Calcium, urine-NTX, urine Ca/Creatinine ratio, 25(OH)D)

Countries

Korea, Republic of

Contacts

Public ContactNam Seok Joo

Ajou University

jchcmc@hanmail.net+82-31-219-5218

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026